Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

NCT05580341 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Genital Wart
CIN
VIN
Papillomavirus Infections

Interventions

BIOLOGICAL: Zerun HPV-9
BIOLOGICAL: GARDASIL ®9

Sponsor

Shanghai Zerun Biotechnology Co.,Ltd

Collaborators

[object Object]